Ming Wei, Zuo Jingjing, Han Jibo, Chen Jinhui
Department of Otolaryngology, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.
Eur Arch Otorhinolaryngol. 2023 May;280(5):2421-2433. doi: 10.1007/s00405-022-07797-7. Epub 2022 Dec 31.
The optimal treatments for adult benign laryngotracheal stenosis presently remains controversial. The majority of the disadvantages of endoscopic interventions with high recurrence rate and open surgical therapy accompanied by sophisticated techniques, complication and mortality, highlights the dilemma of option for treatments.
To compare endoscopic treatments with open surgical interventions in adult patients with benign laryngotracheal stenosis, analyze their clinical outcomes, recurrence, complication and mortality.
In the meta-analysis, the databases including PubMed, Embase, Ovid and Web of Science were searched for studies reporting adult benign laryngotracheal stenosis, and clinical outcomes were compared. The duplicate publications, reviews, comments or letters, conference abstracts, case reports were excluded. The random effect model was used for calculating the pooled effect estimates.
Eight studies (1627 cases) referring to six retrospective and two prospective researches were ultimately included in the meta-analysis. The decreased risk estimates of recurrence rate in patients receiving open surgical interventions were detected, comparing with endoscopic interventions (P < 0.05). Subgroup analysis revealed that decreased risk estimates of restenosis rate were also observed in patients receiving open surgical interventions compared with endoscopic interventions (P < 0.05), based on prospective studies, Europe and America, < 2-year follow-up, laryngeal stenosis, stenotic length without inter-group difference or stenotic grade II alone. However, there were no statistically significant difference of recurrence rate between the two interventions (P > 0.05) based on retrospective studies, South Asia and Africa, ≥ 2-year follow-up, involving tracheal lesion, stenotic length with inter-group difference, or stenotic grades of I-IV. No notable difference in the incidence of complication or mortality were identified.
Open surgical interventions were more suitable for most laryngotracheal stenosis without contraindications. Endoscopic interventions are increasingly being used to treat simple laryngotracheal stenosis, as well as complex airway stenosis in carefully selected cases. Multi-center prospective randomized controlled trials should be conducted to search for the standard treatments for laryngotracheal stenosis.
目前,成人良性喉气管狭窄的最佳治疗方法仍存在争议。内镜干预的大多数缺点是复发率高,而开放手术治疗技术复杂,伴有并发症和死亡率,这凸显了治疗选择的困境。
比较成人良性喉气管狭窄患者的内镜治疗与开放手术干预,分析其临床疗效、复发率、并发症和死亡率。
在荟萃分析中,检索了包括PubMed、Embase、Ovid和Web of Science在内的数据库,以查找报告成人良性喉气管狭窄的研究,并比较临床疗效。排除重复发表的文章、综述、评论或信件、会议摘要、病例报告。采用随机效应模型计算合并效应估计值。
荟萃分析最终纳入了八项研究(1627例),其中包括六项回顾性研究和两项前瞻性研究。与内镜干预相比,接受开放手术干预的患者复发率风险估计值降低(P < 0.05)。亚组分析显示,基于前瞻性研究、欧美地区、随访时间<2年、喉狭窄、狭窄长度无组间差异或仅为II级狭窄,接受开放手术干预的患者再狭窄率风险估计值也低于内镜干预(P < 0.05)。然而,基于回顾性研究、南亚和非洲地区、随访时间≥2年、涉及气管病变、狭窄长度有组间差异或I-IV级狭窄,两种干预措施的复发率无统计学显著差异(P > 0.05)。并发症或死亡率的发生率无显著差异。
对于大多数无禁忌证的喉气管狭窄,开放手术干预更合适。内镜干预越来越多地用于治疗单纯性喉气管狭窄,以及在精心挑选的病例中治疗复杂气道狭窄。应开展多中心前瞻性随机对照试验,以寻找喉气管狭窄的标准治疗方法。